@dansfera: Think FDA site inspections are just random strikes? Think again! 👀 Apparently, the unpredictable 'left field' visits are actually rooted in a sophisticated, risk-based analysis. High enrollment numbers? Potential red flag. Inadequate monitoring? Instant target. This is how today's FDA is deciding who gets the call. Better understand those risk factors if you're involved in site operations! #FDARegulations #ClinicalTrials #SiteAudit #RiskManagement #HealthcareCompliance